投稿系统
Advances in the application of cryotherapy to the treatment of breast cancer
doi: 10.2478/fzm-2023-0016
-
Abstract: Cryotherapy is a minimally invasive treatment. With increasing rate of breast cancer detection, ablation therapy has become an alternative approach for the treatment of this pathology due to its advantages of minimally invasive, fewer complications, good efficacy, and repeatability. Preclinical and clinical studies of cryotherapy for breast cancer published through December 2022 were identified through a literature search using PubMed, ClinicalTrials.gov, and CNKI. This article reviews the progress of cryoablation in the treatment of breast cancer.
-
Key words:
- breast cancer /
- cryoablation
-
Table 1. Comparison of application of cryotherapy in patients with different pathological types of breast cancer
Researcher Pathological classification of breast cancer Sample size Research type Intervention measures Results Morin et al.[20] Invasive breast cancer 25 Randomized controlled clinical trials MRI guided argon-helium cryoablation 13 cases of complete ablation, 2 cases of partial ablation, 10 cases of failure Littrup et al.[21] Invasive breast cancer 11 Randomized controlled clinical trials CT-guided argon-helium cryoablation 11 cases of complete ablation Ward et al.[22] Invasive breast cancer 23 Retrospective study B-ultrasound-guided argon-helium cryoablation 14 cases of complete ablation, 7 cases of partial ablation, 2 cases of failure Pusztaszeri et al.[23] Intraductal breast cancer 11 Randomized controlled clinical trials Argon-helium cryoablation 2 cases of complete ablation, 9 cases of partial ablation 
下载: 导出CSV
-
[1] Barman C, Rath P, Bhattacharya A. A non-fourier bioheat transfer model for cryosurgery of tumor tissue with minimum collateral damage. Comput Methods Programs Biomed, 2021; 200: 105857. doi: 10.1016/j.cmpb.2020.105857 [2] Zouboulis C C, Zouridaki E. Cryosurgery as a single agent and in combination with intralesional corticosteroids is effective on young, small keloids and induces characteristic histological and immunohistological changes: a prospective randomized trial. Dermatology: Int J Clin Invest Dermatol, 2021; 237(3): 396-406. doi: 10.3969/j.issn.1002-1310.2021.03.036 [3] Exterkate L, Peters M, Somford D M, et al. Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer. BJU International, 2021; 128(1): 46-56. doi: 10.1111/bju.15269 [4] Cox J L, Malaisrie S C, Churyla A, et al. Cryosurgery for atrial fibrillation: physiologic basis for creating optimal cryolesions. Ann Thorac Surg, 2021; 112(2): 354-362. doi: 10.1016/j.athoracsur.2020.08.114 [5] Hankiewicz J H, Celinski Z, Camley R E. Measurement of sub-zero temperatures in MRI using T1 temperature sensitive soft silicone materials: applications for MRI-guided cryosurgery. Med Phys, 2021; 48(11): 6844-6858. doi: 10.1002/mp.15252 [6] Swintelski C, Plaza M. Successful cryoablation of breast cancer. Breast J, 2018; 24(4): 704-706. doi: 10.1111/tbj.12996 [7] TAKADAM, TOIM. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. Int J Clin Oncol, 2019; 24(6): 608-613. doi: 10.1007/s10147-019-01448-4 [8] Lian J, Ji Y, Li K. MRI-guided ablation for the treatment of breast cancer: recent progress in clinical application. J Int Radiol, 2020; 29(9): 953-957. [9] Deng X, Wang X, Shen Y. The progress of cryoablation in tumor immunotherapy. Chinese J Cell Biol, 2022; 44(2): 341-349. [10] Van De Voort E M F, Struik G M, Birnie E, et al. Thermal ablation as an alternative for surgical resection of small (≤ 2 cm) breast cancers: a meta-analysis. Clin Breast Cancer, 2021; 21(6): e715-e730. doi: 10.1016/j.clbc.2021.03.004 [11] Hou Y, Sun, X Y, Yao S Y, et al. Cryoablation-activated enhanced nanodoxorubicin release for the therapy of chemoresistant mammary cancer stem-like cells. J Mater Chem B, 2020; 8(5): 908-918. doi: 10.1039/C9TB01922G [12] Holmes D R. Breast cancer care during a pandemic: an opportune time for cryoablation? Breast Cancer Res Treat, 2020; 182(3): 515-521. doi: 10.1007/s10549-020-05724-0 [13] Zhou W, Tang X, Wang S. Application of local microwave ablation in the treatment of breast cancer. J Surg Concepts Pract, 2022; 27(5): 403-405. [14] Takada M, Toi M. Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes. Int J Clin Oncol, 2019; 24(6): 608-613. doi: 10.1007/s10147-019-01448-4 [15] Paepke S, Metz S, Salvago A B, et al. Benign breast tumours-diagnosis and management. Breast Care (Basel), 2018; 13(6): 403-412. doi: 10.1159/000495919 [16] Exterkate L, Peters M, Somford D M, et al. Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer. BJU International, 2021; 128(1): 46-56. doi: 10.1111/bju.15269 [17] Deckers C, De Leijer E M, Flucke U, et al. Curettage and cryosurgery for enchondroma and atypical cartilaginous tumors of the long bones: Oncological results of a large series. J Surg Oncol, 2021; 123(8): 1821-1827. doi: 10.1002/jso.26457 [18] Shigematsu H, Hirata T, Nishina M, et al. Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients. Support Care Cancer, 2020; 28(10): 5005-5011. doi: 10.1007/s00520-020-05345-9 [19] Rosenbaek F, Holm H S, Hjelmborg J V B, et al. Effect of cryotherapy on dose of adjuvant paclitaxel in early-stage breast cancer. Support Care Cancer, 2020; 28(8): 3763-3769. doi: 10.1007/s00520-019-05196-z [20] Morin J, Traore A, Dionne G, et al. Magnetic resonance-guided percutaneous cryosurgery of breast carcinoma: technique and early clinical results. Can J Surg, 2004; 47(5): 347-351 [21] Littrup P J, Jallad B, Chandiwala-Mody P. et al. Cryotherapy for breast cancer: a feasibility study without excision. J Vasc Interv Radiol, 2009; 20(10): 1329-1341. doi: 10.1016/j.jvir.2009.06.029 [22] Ward R C, Lourenco A P, Mainiero M B. Ultrasound-guided breast cancer cryoablation. AJR Am J Roentgenol, 2019; 213(3): 716-722. doi: 10.2214/AJR.19.21329 [23] Pusztaszeri M, Vlastos G, Kinkel K, et al. Histopathological study of breast cancer and normal breast tissue after magnetic resonance-guided cryotherapy ablation. Cryobiology, 2007; 55(1): 44-51. doi: 10.1016/j.cryobiol.2007.05.002 [24] Ho A Y, Tabrizi S, Dunn S A, et al. Current advances in immune checkpoint inhibitor combinations with radiation therapy or cryotherapy for breast cancer. Breast Cancer Res Treat, 2022; 191(2): 229-241. doi: 10.1007/s10549-021-06408-z -
点击查看大图
表(1)
计量
- 文章访问数: 36
- HTML全文浏览量: 45
- PDF下载量: 6
- 被引次数: 0
